信州大学

信州大学医学部

信州大学医学部付属病院

信州大学医学部内科第二教室

  1. ホーム
  2. 第二内科紹介
  3. 業績
  4. 2010年英語論文

業績

2010年英語論文

  1. Akamatsu T, Kaneko Y, Ota H, Miyabayashi H, Arakura N, Tanaka E: Usefulness of double balloon enteroscopy and video capsule endoscopy for the diagnosis and management of primary follicular lymphoma of the gastrointestinal tract in its early stages. Dig Endosc. 22: 33-38; 2010
  2. Akamatsu T, Nagaya T, Ichikawa S, Sudo T, Takeda R, Takenaka K, Kodama R, Ito T, Arakura N, Tanaka E: Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects. J Clin Biochem Nutr. 47: 256-260; 2010
  3. Asano N, Suzuki R, Ohshima K, Kagami Y, Ishida F, Yoshino T, Ogawa H, Morishima Y, Nakamura S: Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma. Int J Hematol. 91: 426-435; 2010
  4. Fujihara N, Haneishi A, Yamauchi K, Terasawa F, Ito T, Ishida F, Okumura N: A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia. Thromb Haemost. 104: 213-223; 2010
  5. Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, Ueda K, Komatsu M, Nagaya T, Joshita S, Kodama R, Tanaka E, Uehara T, Sano K, Tanaka N: Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. J Gastroenterol. 45: 1263-1271; 2010
  6. Ishida F, Kwong YL: Diagnosis and management of natural killer-cell malignancies. Expert Rev Hematol. 3: 593-602; 2010
  7. Ishida F, Nishina S, Asano N, Sasaki S, Sekiguchi N, Nakazawa H, Ito T, Shikama N: Late relapse of extranodal natural killer/T cell lymphoma, nasal type, after more than ten years. Leuk Lymphoma. 51: 171-173; 2010
  8. Ishida F, Okubo K, Ito T, Okumura N, Souri M, Ichinose A: Spontaneous regression of the inhibitor against the coagulation factor XIII A subunit in acquired factor XIII deficiency. Thromb Haemost. 104: 1284-1285; 2010
  9. Ito T, Kitahara K, Umemura T, Ota M, Shimozuru Y, Kawa S, Bahram S: A novel heterophilic antibody interaction involves IgG4. Scand J Immunol. 71: 109-114; 2010
  10. Joshita S, Nakazawa K, Koike S, Kamijo A, Matsubayashi K, Miyabayashi H, Furuta K, Kitano K, Yoshizawa K, Tanaka E: A case of granulocyte-colony stimulating factor-producing hepatocellular carcinoma confirmed by immunohistochemistry. J Korean Med Sci. 25: 476-480; 2010
  11. Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Nakamura M, Ishibashi H, Ota M: Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients. J Hepatol. 53: 537-541; 2010
  12. Joshita S, Umemura T, Yoshizawa K, Katsuyama Y, Tanaka E, Ota M: A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients. Hum Immunol. 71: 520-524; 2010
  13. Joshita S, Yoshizawa K, Sano K, Kobayashi S, Sekiguchi T, Morita S, Kamijo A, Komatsu M, Umemura T, Ichijo T, Matsumoto A, Tanaka E: A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome. Intern Med. 49: 991-994; 2010
  14. Kimura T, Umemura T, Ichijo T, Yamamura N, Tanaka E: Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib. International Journal of Case Reports and Images. 1: 16-18; 2010
  15. Komatsu M, Tong Y, Li Y, Nakajima T, Li G, Hu R, Sugiyama E, Kamijo Y, Tanaka N, Hara A, Aoyama T: Multiple roles of PPARalpha in brown adipose tissue under constitutive and cold conditions. Genes Cells. 15: 91-100; 2010
  16. Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y: Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan. Hepatol Res. 40: 1-7; 2010
  17. Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y: Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res. 40: 8-13; 2010
  18. Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E: Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B Shinshu Medical Journal. 58: 153-162; 2010
  19. Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T: Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 53: 724-731; 2010
  20. Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T: Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice. Redox Rep. 15: 123-130; 2010
  21. Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y: Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment. Dig Dis Sci. 55: 2095-2101; 2010
  22. Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T: Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice. Biochem Pharmacol. 80: 1601-1612; 2010
  23. Tsuruta G, Tanaka N, Hongo M, Komatsu M, Horiuchi A, Hamamoto K, Iguchi C, Nakayama Y, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E: Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. J Gastroenterol. 45: 666-672; 2010
  24. Tsutsui M, Tanaka N, Kawakubo M, Sheena Y, Horiuchi A, Komatsu M, Nagaya T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Aoyama T, Tanaka E, Sano K: Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels. J Clin Gastroenterol. 44: 440-447; 2010
  25. Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y, Tanaka E, Honda T, Ota H: Chronic gastritis in the setting of autoimmune pancreatitis. Am J Surg Pathol. 34: 1241-1249; 2010
  26. Umemura T, Zen Y, Nakanuma Y, Kiyosawa K: Another cause of autoimmune hepatitis. Hepatology. 52: 389-390; 2010

更新情報

更新情報
内科学第二教室からのお知らせや更新情報を掲載しています。

医学生・研修医の方へ

医学生・研修医の方へ
医学生や研修生に向けた研修案内や大学院研修案内などを紹介しています。

同門会会報

同門会会報
第二内科 医学生・研修医の方へ 医学生・研修医の方へ 研修案内 大学院研修案内
  • 信州大学医学部
  • 信大医学部附属病院
  • 信州大学医学部内科学第二教室
    〒390-8621 長野県松本市旭3-1-1
    TEL : 0263-37-2634
    FAX : 0263-32-9412
    MAIL : ninai@shinshu-u.ac.jp